Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.

Publication

Citation
Ulven T, Receveur JM, Grimstrup M, Rist Ø, Frimurer TM, Gerlach LO, Mathiesen JM, Kostenis E, Uller L, Högberg T.: Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits. J Med Chem, Volume 49 (23), 2006
Authors
Frimurer TM, Gerlach LO, Grimstrup M, Högberg T., Kostenis E, Mathiesen JM, Receveur JM, Uller L, Ulven T
Journal
J Med Chem
Year
2006
PubMed
17154491
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc
Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits. | MolMeDB